These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

322 related articles for article (PubMed ID: 22048522)

  • 1. Prediction of in vivo hepatic clearance and half-life of drug candidates in human using chimeric mice with humanized liver.
    Sanoh S; Horiguchi A; Sugihara K; Kotake Y; Tayama Y; Ohshita H; Tateno C; Horie T; Kitamura S; Ohta S
    Drug Metab Dispos; 2012 Feb; 40(2):322-8. PubMed ID: 22048522
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Predictability of metabolism of ibuprofen and naproxen using chimeric mice with human hepatocytes.
    Sanoh S; Horiguchi A; Sugihara K; Kotake Y; Tayama Y; Uramaru N; Ohshita H; Tateno C; Horie T; Kitamura S; Ohta S
    Drug Metab Dispos; 2012 Dec; 40(12):2267-72. PubMed ID: 22936315
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prediction of human metabolism of FK3453 by aldehyde oxidase using chimeric mice transplanted with human or rat hepatocytes.
    Sanoh S; Nozaki K; Murai H; Terashita S; Teramura T; Ohta S
    Drug Metab Dispos; 2012 Jan; 40(1):76-82. PubMed ID: 21984595
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development of Murine Cyp3a Knockout Chimeric Mice with Humanized Liver.
    Kato K; Ohbuchi M; Hamamura S; Ohshita H; Kazuki Y; Oshimura M; Sato K; Nakada N; Kawamura A; Usui T; Kamimura H; Tateno C
    Drug Metab Dispos; 2015 Aug; 43(8):1208-17. PubMed ID: 25979261
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Near completely humanized liver in mice shows human-type metabolic responses to drugs.
    Tateno C; Yoshizane Y; Saito N; Kataoka M; Utoh R; Yamasaki C; Tachibana A; Soeno Y; Asahina K; Hino H; Asahara T; Yokoi T; Furukawa T; Yoshizato K
    Am J Pathol; 2004 Sep; 165(3):901-12. PubMed ID: 15331414
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of hepatitis C virus infection on the mRNA expression of drug transporters and cytochrome p450 enzymes in chimeric mice with humanized liver.
    Kikuchi R; McCown M; Olson P; Tateno C; Morikawa Y; Katoh Y; Bourdet DL; Monshouwer M; Fretland AJ
    Drug Metab Dispos; 2010 Nov; 38(11):1954-61. PubMed ID: 20693416
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A unified model for predicting human hepatic, metabolic clearance from in vitro intrinsic clearance data in hepatocytes and microsomes.
    Riley RJ; McGinnity DF; Austin RP
    Drug Metab Dispos; 2005 Sep; 33(9):1304-11. PubMed ID: 15932954
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prediction of human metabolism of the sedative-hypnotic zaleplon using chimeric mice transplanted with human hepatocytes.
    Tanoue C; Sugihara K; Uramaru N; Tayama Y; Watanabe Y; Horie T; Ohta S; Kitamura S
    Xenobiotica; 2013 Nov; 43(11):956-62. PubMed ID: 23651075
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chimeric mice with humanized liver.
    Katoh M; Tateno C; Yoshizato K; Yokoi T
    Toxicology; 2008 Apr; 246(1):9-17. PubMed ID: 18248870
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Current status of prediction of drug disposition and toxicity in humans using chimeric mice with humanized liver.
    Kitamura S; Sugihara K
    Xenobiotica; 2014 Jan; 44(2):123-34. PubMed ID: 24329499
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chimeric mice transplanted with human hepatocytes as a model for prediction of human drug metabolism and pharmacokinetics.
    Sanoh S; Ohta S
    Biopharm Drug Dispos; 2014 Mar; 35(2):71-86. PubMed ID: 24114658
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Validation of uPA/SCID mouse with humanized liver as a human liver model: protein quantification of transporters, cytochromes P450, and UDP-glucuronosyltransferases by LC-MS/MS.
    Ohtsuki S; Kawakami H; Inoue T; Nakamura K; Tateno C; Katsukura Y; Obuchi W; Uchida Y; Kamiie J; Horie T; Terasaki T
    Drug Metab Dispos; 2014 Jun; 42(6):1039-43. PubMed ID: 24711249
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of the pharmacokinetics, biotransformation and hepatic transporter effects of troglitazone in mice with humanized livers.
    Schulz-Utermoehl T; Sarda S; Foster JR; Jacobsen M; Kenna JG; Morikawa Y; Salmu J; Gross G; Wilson ID
    Xenobiotica; 2012 Jun; 42(6):503-17. PubMed ID: 22201515
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of predictability for human pharmacokinetics parameters among monkeys, rats, and chimeric mice with humanised liver.
    Miyamoto M; Iwasaki S; Chisaki I; Nakagawa S; Amano N; Hirabayashi H
    Xenobiotica; 2017 Dec; 47(12):1052-1063. PubMed ID: 27892765
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prediction of Human Hepatic Clearance for Cytochrome P450 Substrates via a New Culture Method Using the Collagen Vitrigel Membrane Chamber and Fresh Hepatocytes Isolated from Liver Humanized Mice.
    Watari R; Kakiki M; Yamasaki C; Ishida Y; Tateno C; Kuroda Y; Ishida S; Kusano K
    Biol Pharm Bull; 2019; 42(3):348-353. PubMed ID: 30828066
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human pharmacokinetic prediction of UDP-glucuronosyltransferase substrates with an animal scale-up approach.
    Deguchi T; Watanabe N; Kurihara A; Igeta K; Ikenaga H; Fusegawa K; Suzuki N; Murata S; Hirouchi M; Furuta Y; Iwasaki M; Okazaki O; Izumi T
    Drug Metab Dispos; 2011 May; 39(5):820-9. PubMed ID: 21282406
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of cryopreserved HepaRG cells with cryopreserved human hepatocytes for prediction of clearance for 26 drugs.
    Zanelli U; Caradonna NP; Hallifax D; Turlizzi E; Houston JB
    Drug Metab Dispos; 2012 Jan; 40(1):104-10. PubMed ID: 21998403
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quantitative Prediction of Human Hepatic Clearance for P450 and Non-P450 Substrates from In Vivo Monkey Pharmacokinetics Study and In Vitro Metabolic Stability Tests Using Hepatocytes.
    Nishimuta H; Watanabe T; Bando K
    AAPS J; 2019 Jan; 21(2):20. PubMed ID: 30673906
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of recombinant cytochrome P450 enzymes as an in vitro system for metabolic clearance predictions.
    Stringer RA; Strain-Damerell C; Nicklin P; Houston JB
    Drug Metab Dispos; 2009 May; 37(5):1025-34. PubMed ID: 19196847
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prediction of human pharmacokinetics--evaluation of methods for prediction of hepatic metabolic clearance.
    Fagerholm U
    J Pharm Pharmacol; 2007 Jun; 59(6):803-28. PubMed ID: 17637173
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.